We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Laura Elizabeth Lansdowne

Science Writer

Writes for:

Drug Discovery Cancer Research

Latest Content From Laura Elizabeth Lansdowne

Screening Living Cells at High-speed
Blog

We recently spoke with Eric Hobbs, CEO at Berkeley Lights to learn more about "digital cell biology". Erik also describes how optofluidics can be used to gain fast, comprehensive measurements and insights across thousands of cells in parallel.

VIEW

Cell Culture Evolution – A Revolution for Drug Discovery
Article

Two-dimensional cell cultures have played a role in the drug discovery and development process for decades, however in recent years three-dimensional (3D) cell culture has taken center stage. Here we take a look at the evolution of cell culture, the rise of 3D, and how the industry’s shift from “static” to “fluidic” is inspiring the next generation of in vitro models.

VIEW

Uniting Stakeholders to Streamline Drug Discovery
Blog

We recently spoke with Tyler Golato, Lead Scientist at Molecule, to learn more about the "innovation crisis", the factors directly impacting the types of therapeutics being brought to market, and how by uniting stakeholders it is possible to streamline the drug development pipeline.

VIEW

Standardizing Robotics and Automation in the Lab
Article

We often come across terms such as "Lab of the Future" and "Smart Lab" – but what do these actually mean? We recently spoke to Dr Patrick Courtney, member of the Board of Directors of SiLA (Standards in Laboratory Automation) to learn more about the value of implementing laboratory robotics and automation.

VIEW

Automating Research to Improve Reproducibility and Throughput
Article

For several decades mankind has looked to automate tedious and error-prone manual steps carried out in the laboratory, with a goal to improve scientific reproducibility and throughput. We recently spoke to Charles Fracchia, CEO and Co-Founder of BioBright, to learn how automation can be adopted to help researchers analyze their data.

VIEW

Injecting Dying Cells to Trigger Tumor Destruction
News

By directly injecting engineered dying cells into tumors, researchers have successfully triggered the immune system to attack the cancerous cells at multiple sites within the body and reduce tumor growth, in mice.

VIEW

A Sweet Surprise: Targeting Sugar-coated Proteins to Treat Pancreatitis
News

CA19-9 – a complex sugar structure that coats many proteins, has now been linked to the transformation of pancreatitis to pancreatic cancer, according to a new study published in Science.

VIEW

Modern Milestones in Cancer Research
Infographic

Tremendous progress has been made in the cancer research field over the past 20 years. This infographic highlights 10 major milestones since the year 2000.

VIEW

Addressing Gender Bias – “It Is Time to End the Tradition in Science of All-Male Speaking Panels”
Article

Francis S. Collins, M.D., Ph.D. Director of the National Institutes of Health, has recently directly addressed the issue of underrepresented groups in science: "Too often, women and members of other groups underrepresented in science are conspicuously missing in the marquee speaking slots at scientific meetings and other high-level conferences.”

VIEW

Developing a Single-shot Vaccine Against Chikungunya
Blog

Chikungunya is a viral disease which can be transmitted via the bite of a mosquito infected with the chikungunya virus (CHIKV). Currently there is no preventative vaccine approved for use. We recently spoke with Thomas Lingelbach, CEO at Valneva to learn more about the development of the company's chikungunya vaccine candidate and the results of their recent Phase 1 clinical study.

VIEW